BMO and TD joined a lending syndicate and acted as co-lead arrangers for a financing facility for Cannara Biotech Inc.
1 report, 1 independent
Updated Sep 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
BMO and TD joined a lending syndicate and acted as co-lead arrangers for a financing facility for Cannara Biotech Inc.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Bank of Montreal
Canadian investment bank
- Insider trading activities reported on September 28, 2026, include a Chair acquiring shares of BCE Inc., a Chief Risk Officer selling BMO shares, and a CEO purchasing Altus Group Ltd. shares.
- BMO manages an ETF listed on the TSX that invests in U.S. large cap equity under Canadian securities legislation.
-
Toronto-Dominion Bank
banking and financial services corporation
Related events
- Bank of Montreal led a credit facility syndication involving Royal Bank of Canada, National Bank of Canada, and Scotiabank.
- Jefferies Financial Group is covering the Canadian banking industry, while Darryl White discusses AI impacts at BMO, concurrent with Bank of Canada job market estimates.
- A company based in Montreal is successfully leveraging its office to provide trade finance technology and modernization support to financial institutions like ANZ, Barclays, and TD Bank.
- BMO's performance relative to its industry group and the broader finance sector was analyzed on August 4, 2025.